SCHEMBL22041620

SCHEMBL22041620

O=C(Oc1c(Br)c(Br)cc2cc(C(=O)O)c(=O)oc12)c1ccco1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 12/20 0.53
▸ GAA P10253 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ MAOA P21397 1/20 0.42
▸ HPGD P15428 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ S1PR2 O95136 1/20 0.42
▸ S1PR4 O95977 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ S1PR1 P21453 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ CASP7 P55210 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ MAOB P27338 2/20 0.41
▸ CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22041628 0.82 GPR35 (0.47) GPR35GAAALDH1A1TSHRMAPK1
SCHEMBL22041604 0.81 GPR35 (0.55) GPR35ALDH1A1TSHRMAOAHPGD
SCHEMBL22041599 0.81 GPR35 (0.52) GPR35ALDH1A1TSHRMAOAHPGD
SCHEMBL22041600 0.81 GPR35 (0.52) GPR35ALDH1A1TSHRMAOAHPGD
SCHEMBL22041636 0.81 GPR35 (0.49) GPR35GAAALDH1A1TSHRMAOA
SCHEMBL22041627 0.81 ALDH1A1 (0.58) GPR35GAAALDH1A1TSHRMAPK1
SCHEMBL22041935 0.81 GPR35 (0.51) GPR35ALDH1A1TSHRMAOAHPGD
SCHEMBL22041622 0.81 GPR35 (0.51) GPR35GAAALDH1A1MAOAHPGD
SCHEMBL22041632 0.81 GPR35 (0.51) GPR35ALDH1A1TSHRMAOAHPGD
SCHEMBL22041626 0.80 GPR35 (0.64) GPR35MAOAHPGDUSP2CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO claimed
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO disclosed
Send feedback